Cdk5‐Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Inflammasomes, which mediate the activation of caspase‐1 and maturation of IL‐1β and IL‐18, have been unambiguously verified to participate in many diseases, such as lung diseases, infectious diseases and Alzheimer's disease, but the relation between Parkinson's disease and inflammasomes is poorly understood. Methods: The expression, maturation, and secretion of inflammasomes in neurons were measured. The activation of inflammasomes in the substantia nigra of the brain was tested in acute 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine and an α‐synuclein transgenic mouse model. The levels of IL‐1β and IL‐18 in cerebrospinal fluid and serum samples of Parkinson's disease (PD) patients and control subjects were measured. The role of cyclin‐dependent kinase 5 (Cdk5) in neuronal inflammasome activation was evaluated using the pharmacological Cdk5 inhibitor roscovitine or Cdk5‐targeted deletion. Results: Here, we observed the expression of core molecules of inflammasomes, including NALP3, ASC, caspase‐1, and IL‐1β, in neuronal cells. The PD inducer rotenone could activate neuronal inflammasomes and promote the maturation and secretion of the cleaved IL‐1β and IL‐18 in a dose‐ and time‐dependent manner. We also detected the activation of inflammasomes in the substantia nigra of a PD mouse model and in cerebrospinal fluid of PD patients. Furthermore, Cdk5 is required for the activation of inflammasomes, and both inhibition and deletion of Cdk5 could efficiently block inflammasome activation in PD models. Conclusions: Together, our results indicated that Cdk5‐dependent activation of neuronal inflammasomes was involved in the progression of PD. © 2016 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · cited 1×
“Recently, considerable evidence has indicated that excessive ROS generation and mtDNA release by mitochondria promote the activation of inflammasomes in multiple diseases such as rheumatoid arthritis (RA), lung disease, infectious diseases, and Alzheimer’s disease (AD).(9-13) PD has also generally been considered a me…”
BackgroundParkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease
Shukla, V., Skuntz, S., & Pant, H. C. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.015 · Cited by 185
Mitochondrial control of the NLRP3 inflammasome
Kepp, O., Galluzzi, L., & Kroemer, G. (2011) · Nature Immunology · doi:10.1038/ni0311-199 · Cited by 168 · cited 1×
“Recently, considerable evidence has indicated that excessive ROS generation and mtDNA release by mitochondria promote the activation of inflammasomes in multiple diseases such as rheumatoid arthritis (RA), lung disease, infectious diseases, and Alzheimer’s disease (AD).(9-13) PD has also generally been considered a me…”
BackgroundKanagaraj, N., Beiping, H., Dheen, S. T., & Tay, S. S. W. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.039 · Cited by 130
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
Simon, D. K., Lin, M. T., Zheng, L., Liu, G.-J., Ahn, C. H., Kim, L. M., Mauck, W. M., Twu, F., Beal, M. F., & Johns, D. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00037-x · Cited by 118 · cited 1×
“Numerous recent studies indicate that mitochondria-related oxidative stress (for example, the excessive generation of reactive oxygen species [ROS]) and mitochondrial DNA (mtDNA) can cause CNS tissue damage during inflammatory processes in the progression of PD.(2-6) The inflammasome, a molecular platform that trigger…”
Background
Cited by
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease
Wang, S., Yuan, Y.-H., Chen, N.-H., & Wang, H.-B. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 444
Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186
The Role of the Inflammasome in Neurodegenerative Diseases
Piancone, F., La Rosa, F., Marventano, I., Saresella, M., & Clerici, M. (2021) · Molecules · doi:10.3390/molecules26040953 · Cited by 144
Feng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96
Metadata
- Authors
- Zhang, P., Shao, X., Qi, G., Chen, Q., Bu, L., Chen, L., Shi, J., Ming, J., & Tian, B.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2016-02-08
- Volume
- 31
- Issue
- 3
- Pages
- 366-376
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2260110125
- Cited by
- 102
- References
- 7
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cdk5‐Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease. https://app.cochat.ai/papers/10.1002/mds.26488
- The paper
- Zhang, P., Shao, X., Qi, G., Chen, Q., Bu, L., Chen, L., Shi, J., Ming, J., & Tian, B. (2016). Cdk5‐Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.26488
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.